Sort
34,240 grants matching “atherosclerosis”
Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic disease
$473,989Michael Andrew Fischbach · Cleveland Clinic Lerner Com-Cwru · P01 · FY2021 · HL
Mechanisms of myelopoiesis after myocardial infarction
$473,879Partha Dutta · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HL
Mechanisms of myelopoiesis after myocardial infarction
$473,829Partha Dutta · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
Metabolic Control by Myogenic MicroRNAs, Mediator and Myokines
$473,800Eric N Olson · Ut Southwestern Medical Center · R01 · FY2013 · DK
SLEEP HEART HEALTH STUDY
$473,767New York University School Of Medicine · U01 · FY2000 · HL
Proteomic Analysis of Plasminogen Receptors
$473,750Lindsey A Miles · Scripps Research Institute, The · R01 · FY2009 · HL
Proteomic Analysis of Plasminogen Receptors
$473,750Lindsey A Miles · Scripps Research Institute, The · R01 · FY2010 · HL
Proteomic Analysis of Plasminogen Receptors
$473,750Lindsey A Miles · Scripps Research Institute, The · R01 · FY2011 · HL
Proteomic Analysis of Plasminogen Receptors
$473,750Lindsey A Miles · Scripps Research Institute, The · R01 · FY2008 · HL
Carotid Atherosclerosis (MRI) Progression Study (CAMP)
$473,687Wake Forest University Health Sciences · R01 · FY2004 · HL
TTC39B in Metabolism
$473,466Alan Richard Tall · Columbia University Health Sciences · R01 · FY2021 · HL
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin
$473,421Gregory Burke · Wake Forest University Health Sciences · N01 · FY2020 · HL
Molecular Biology and Function of PECAM-1
$473,262Peter J Newman · Versiti Wisconsin, Inc. · R01 · FY2012 · HL
Molecular Biology and Function of PECAM-1
$473,256Peter J Newman · Versiti Wisconsin, Inc. · R01 · FY2011 · HL
Molecular Biology and Function of PECAM-1
$473,212Peter J Newman · Versiti Wisconsin, Inc. · R01 · FY2010 · HL
Anti-atherogenic Mechanisms of the Dual Rho-GEF Kalirin
$473,143Neil J. Freedman · Duke University · R01 · FY2016 · HL
Anti-atherogenic Mechanisms of the Dual Rho-GEF Kalirin
$473,143Neil J. Freedman · Duke University · R01 · FY2017 · HL
VWF Activity: Molecular Biology, Ethnic Diversity and Disease Associations
$473,116Jing-Fei Dong · Bloodworks · R01 · FY2018 · HL
PPARgamma, Endothelial Inflammation, and Atherosclerosis
$473,112Jun-Ichi Abe · University Of Rochester · P01 · FY2008 · HL
Novel regulatory mechanisms controlling hepatic apoB-Lp lipid loading and secretion
$473,104Edward A Fisher · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2024 · HL
Contribution of nonrenal calcitriol production in chronic inflammation
$473,050Mark B Meyer · University Of Wisconsin-Madison · R01 · FY2022 · HL
Contribution of nonrenal calcitriol production in chronic inflammation
$473,050Mark B Meyer · University Of Wisconsin-Madison · R01 · FY2021 · HL
Novel regulatory mechanisms controlling hepatic apoB-Lp lipid loading and secretion
$473,046Edward A Fisher · Nyu Long Island School Of Medicine · P01 · FY2023 · HL
Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS
$473,033Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · NS
PROTEIN Z DEPENDENT PROTEINASE INHIBITOR
$472,943George J Broze · Washington University · R01 · FY2011 · HL